"Le Groupement Hospitalier de Territoire Caux Maritime compte 7 établissements avec une direction commune : le CH de Dieppe (avec la Résidence du Château), de Eu, de Saint-Valery-En-Caux et les EHPAD de Luneray, Le Tréport, Saint-Crespin et Envermeu. Le Centre Hospitalier de Dieppe est l'établissement support. L'institut de Formation aux Soins Infirmiers et l'Institut de Formation d'Aides Soignants de Dieppe sont, également, rattachés au CH de Dieppe"

During the past decade, CH Dieppe conducted 15 clinical trials. In the 10-year time frame, 15 clinical trials started and 1 clinical trials were completed, i.e. on average, 6.7% percent of trials that started reached the finish line to date. In the past 5 years, 6 clinical trials started and 1 clinical trials were completed. i.e. 16.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "CH Dieppe" #1 sponsor was "University Hospital, Rouen" with 4 trials, followed by "Centre Hospitalier Departemental Vendee" with 3 trials sponsored, "Nantes University Hospital" with 3 trials sponsored, "Ictal Group" with 2 trials sponsored and "Assistance Publique - Hôpitaux de Paris" with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 16 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "CH Dieppe" #1 collaborator was "University Hospital, Tours" with 4 trials as a collaborator, "Institut National de la Santé Et de la Recherche Médicale, France" with 3 trials as a collaborator, "Ministry of Health, France" with 3 trials as a collaborator, "ADIR Association" with 1 trials as a collaborator and "Assistance Publique - Hôpitaux de Paris" with 1 trials as a collaborator. Other collaborators include 4 different institutions and companies that were collaborators in the rest 14 trials.

According to Clinical.Site data, the most researched conditions in "CH Dieppe" are "Shock" (4 trials), "Acute Respiratory Failure" (3 trials), "COVID-19" (2 trials), "Septic Shock" (2 trials) and "Acute Renal Failure (as Defined by the "Failure" Stage of the RIFLE Classification)" (1 trials). Many other conditions were trialed in "CH Dieppe" in a lesser frequency.

Most popular intervention types in "CH Dieppe" are "Other" (9 trials), "Procedure" (6 trials), "Device" (4 trials), "Drug" (2 trials) and "Biological" (1 trials). Other intervention types were less common.

The name of intervention was led by "Parenteral nutrition" (2 trials), "Administering diagnosis orientation questionnaires for the screening of possible sleep disorders" (1 trials), "Assessment by caregivers of the quality of the end of life in intensive care units" (1 trials), "Atrial Fibrillation ablation procedure" (1 trials) and "Clinutren 1.5 ®, Nestlé Clinical Nutrition" (1 trials). Other intervention names were less common.

The vast majority of trials in "CH Dieppe" are 24 trials for "All" genders.

Currently, there are NaN active trials in "CH Dieppe". undefined are not yet recruiting, 7 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 11 completed trials in CH Dieppe, undefined suspended trials, and 4 terminated clinical trials to date.

Out of the total trials that were conducted in CH Dieppe, 0 "Phase 1" clinical trials were conducted, 2 "Phase 2" clinical trials and 4 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 8 trials that are defined as “Not Applicable".